PMCK Berhad, a leading healthcare services provider in Northern Malaysia, has received approval from Bursa Malaysia Securities Berhad to list on the ACE Market. This marks a significant step forward in PMCK’s expansion strategy, particularly with the development of PMC Kulim—a state-of-the-art private medical centre designed to enhance healthcare accessibility in the region.

PMCK’s Vision for Better Healthcare

PMCK Berhad currently operates a flagship private medical centre in Alor Setar, offering:

• Specialist consultant services
• Emergency care
• Clinical support

With PMC Kulim, PMCK aims to bridge the healthcare gap by providing accessible, affordable, and patient-focused medical services. The new facility will cater to underserved populations in Kulim, Bandar Baharu, and nearby districts, addressing the region’s shortage of private healthcare infrastructure.

How the IPO Fuels Growth

The IPO will issue 272.6 million new shares (25% of enlarged issued share capital), with proceeds allocated for:

• Repaying bank borrowings tied to PMC Kulim’s construction
• Acquiring medical equipment for PMC Kulim
• Covering listing-related expenses

“PMC Kulim is not just a hospital—it is a holistic ecosystem designed to elevate healthcare accessibility in the region,” said PMCK Berhad Managing Director, Dato’ Lee Gaik Cheng.

The facility will be a 12-storey medical centre, integrated with a seven-storey mixed-use development featuring:

• Hotel accommodations for patients’ families
• Food courts and public amenities
• 90 in-patient beds, operating theatres, labour rooms, nursery units, and 15 specialist clinics

With only 7.72 private hospital beds per 10,000 people in Northern Malaysia (compared to 17.71 in Kuala Lumpur), PMC Kulim will fill a critical gap in healthcare services.

Investing in a Healthier Future

PMCK’s financial strength underpins its expansion. In FYE 2024, the company reported:

• Revenue of RM104.34 million (up from RM99.85 million in FYE 2023)
• Net profit growth of nearly 40%, reaching RM15.02 million
• Over 115,000 to 128,000 patients treated from 2022 to 2024
• 40 specialist consultants across 17 specialisations

After listing, PMCK will consolidate its other businesses in Kulim—Poliklinik Unik and Klinik Pergigian Unik—under PMC Kulim, enhancing operational efficiency and long-term sustainability.

“Our goal is to bridge the healthcare divide in Northern Malaysia. This listing marks a significant milestone for PMCK Berhad, and we are now poised to deliver world-class care closer to home,” added Dato’ Lee.

Key Takeaways:

• PMCK Berhad gains Bursa approval for ACE Market IPO
• PMC Kulim will be a game-changer for Northern Malaysia’s healthcare system
• IPO proceeds will fund hospital construction, equipment acquisition, and operational growth
• PMCK is on track for strong financial growth and long-term expansion

Stay Updated!

For the latest updates on PMCK Berhad’s IPO and healthcare expansion, follow PMCK’s official channels. Investors and healthcare professionals can explore opportunities as PMCK strengthens its position as a leading private healthcare provider in Malaysia.

Visit the PMCK website here: https://pmck.com.my.